Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation
- 30 November 2010
- journal article
- Published by Elsevier BV in Toxicology Letters
- Vol. 199 (2), 115-122
- https://doi.org/10.1016/j.toxlet.2010.08.010
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Disruption of SM22 Promotes Inflammation After Artery Injury via Nuclear Factor κB ActivationCirculation Research, 2010
- MicroRNA Regulatory Networks in Cardiovascular DevelopmentDevelopmental Cell, 2010
- Cyclosporine Up-Regulates Krüppel-Like Factor-4 (KLF4) in Vascular Smooth Muscle Cells and Drives Phenotypic Modulation In VivoJournal of Pharmacology and Experimental Therapeutics, 2010
- Smooth muscle phenotypic modulation is an early event in aortic aneurysmsThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Disruption of actin cytoskeleton mediates loss of tensile stress induced early phenotypic modulation of vascular smooth muscle cells in organ cultureExperimental and Molecular Pathology, 2009
- Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in AtherosclerosisJournal of Vascular Research, 2009
- Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotypeCardiovascular Research, 2009
- Resveratrol Improves Endothelial FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscleAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003